Australia markets closed

Crescita Therapeutics Inc. (CRRTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.32050.0000 (0.00%)
At close: 12:28PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
25,057
17,522
23,525
16,769
15,640
Cost of revenue
11,109
7,158
10,343
6,755
4,367
Gross profit
13,948
10,364
13,182
10,014
11,273
Operating expenses
Research development
620
699
609
634
1,101
Selling general and administrative
10,815
10,115
10,573
8,720
7,126
Total operating expenses
12,876
12,320
12,653
10,733
9,718
Operating income or loss
1,072
-1,956
529
-719
1,555
Interest expense
196
85
158
236
252
Total other income/expenses net
-369
4
-227
-236
-1,074
Income before tax
723
-1,530
404
-1,009
520
Income tax expense
456
456
-458
96
483
Income from continuing operations
627
-1,986
862
-1,105
37
Net income
627
-1,986
862
-1,105
37
Net income available to common shareholders
627
-1,986
862
-1,105
37
Basic EPS
-0.03
-
0.04
-0.05
0.00
Diluted EPS
-0.03
-
0.04
-0.05
0.00
Basic average shares
20,356
-
20,691
20,755
20,661
Diluted average shares
20,666
-
21,000
20,755
20,969